Role of p14(ARF) alterations in endometrial tumorigenesis: a mini-review.
In the current mini-review, we present a short overview of genetic as well as immunohistochemical p14(ARF) alterations either in primary human endometrial carcinomas (ECs) or in metastatic lesions originated from malignant endometrium. The prognostic utility of p14(ARF) in uterine malignancies has also been briefly discussed.
2nd Department of Gynecology, Lublin Medical University, Lublin, Poland. andrzej.semczuk@am.lublin.pl
Andrzej
A
Semczuk
Klaudiusz
K
Cieplinski
Atanas
A
Ignatov
Piotr
P
Olcha
Tomasz
T
Rechberger
D002471:Cell Transformation, Neoplastic; D016889:Endometrial Neoplasms / Q000378:metabolism*; D005260:Female; D006801:Humans; D025803:Tumor Suppressor Protein p14ARF / Q000378:metabolism*
D025803:Tumor Suppressor Protein p14ARF